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Key Points
Question
Are some patients undergoing incomplete revascularization (IR) with percutaneous coronary interventions
at higher risk than others?
Findings
In this registry-based study, patients with IR in a vessel with at least 90% stenosis were at higher risk than
other patients with IR. More than 20% of all patients with percutaneous coronary interventions had IR of 2
or more vessels, and more than 30% had IR with more than 90% stenosis.
Meaning
Patients with percutaneous coronary interventions with IR are at higher risk of mortality if they have IR
with at least 90% stenosis, IR in 2 or more vessels, or proximal left anterior descending artery IR.
Abstract
Importance
Many studies have compared outcomes for incomplete revascularization (IR) among patients undergoing
percutaneous coronary interventions (PCI), but little is known about whether outcomes are related to the
nature of the IR.
Objective
To determine whether some coronary vessel characteristics are associated with worse outcomes in patients
with PCI with IR.
Design, Setting, and Participants
New York’s PCI registry was used to examine mortality (median follow-up, 3.4 years) as a function of the
number of vessels that were incompletely revascularized, the stenosis in those vessels, and whether the
proximal left anterior descending artery was incompletely revascularized after controlling for other factors
associated with mortality for patients with and without ST-elevation myocardial infarction (STEMI). This
was a multicenter study (all nonfederal PCI hospitals in New York State) that included 41 639 New York
residents with multivessel coronary artery disease undergoing PCI in New York State between January 1,
2010, and December 31, 2012.
Exposures
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Percutaneous coronary interventions, with complete and incomplete revascularization.
Main Outcomes and Measures
Medium-term mortality.
Results
For patients with STEMI, the mean age was 62.8 years; 26.2% were women, 11.9% were Hispanic, and
81.5% were white. For other patients, the mean age was 66.6 years, 29.1% were women, 11.3% were
Hispanic, and 79.1% were white. Incomplete revascularization was very common (78% among patients
with STEMI and 71% among other patients). Patients with IR in a vessel with at least 90% stenosis were at
higher risk than other patients with IR. This was not significant among patients with STEMI (17.18% vs
12.86%; adjusted hazard ratio [AHR], 1.16; 95% CI, 0.99-1.37) and significant among patients without
STEMI (17.71% vs 12.96%; AHR, 1.15; 95% CI, 1.07-1.24). Similarly, patients with IR in 2 or more
vessels had higher mortality than patients with completely revascularization and higher mortality than
other patients with IR among patients with STEMI (20.37% vs 14.39%; AHR, 1.35; 95% CI, 1.15-1.59)
and among patients without STEMI (20.10% vs 12.86%; AHR, 1.17; 95% CI, 1.09-1.59). Patients with
proximal left anterior descending artery vessel IR had higher mortality than other patients with IR (20.09%
vs 14.67%; AHR, 1.31; 95% CI, 1.04-1.64 for patients with STEMI and 20.78% vs 15.62%; AHR, 1.11;
95% CI, 1.01-1.23 for patients without STEMI). More than 20% of all PCI patients had IR of 2 or more
vessels and more than 30% had IR with more than 90% stenosis.
Conclusions and Relevance
Patients with IR are at higher risk of mortality if they have IR with at least 90% stenosis, IR in 2 or more
vessels, or proximal left anterior descending IR.
Introduction
Numerous studies have found that patients with multivessel coronary artery disease who undergo
incomplete revascularization (IR) with percutaneous coronary interventions (PCIs) experience higher
mortality and/or complication rates than their counterparts who undergo complete revascularization (CR).
However, little is known about whether the specific vessels that are incompletely revascularized or the
degree of stenosis in those vessels are associated with differential mortality rates.
The primary purposes of this study were to contrast mortality rates for patients undergoing PCI with CR
with (1) patients undergoing PCI with IR having different ranges of stenosis, (2) patients having different
numbers of vessels with IR, and (3) patients with IR in the proximal left anterior descending (PLAD)
artery.
Methods
Databases
The databases used to conduct the study were New York’s Percutaneous Coronary Interventions Reporting
System and New York’s Vital Statistics file. The Percutaneous Coronary Interventions Reporting System
was created in 1992 to evaluate and improve the quality of PCI in New York through the risk adjustment of
outcomes and dissemination of reports to hospitals, cardiologists, and the public. It contains demographics;
patient risk factors; complications; hospital and cardiologist identifiers; admission, discharge, and
procedure dates; and discharge disposition for all PCI procedures performed in nonfederal hospitals in the
state. Also included are lesion-specific information that identifies all diseased lesions, attempted lesions,
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and the stenosis before and after attempting PCI. Intended staged procedures are also reported at the initial
procedure and at the time of the staged procedure. A procedure is regarded as staged only if it is reported
at both times.
Data are audited for completeness and accuracy by matching to New York’s acute care hospital
administrative database, the Statewide Planning and Research Cooperative System, and by reviewing
medical records from hospitals. A total of 60 hospitals performed PCI in the state in 2012. Vital statistics
data were matched to the Percutaneous Coronary Interventions Reporting System using unique patient
identifiers to obtain deaths that occurred after discharge following the index PCI procedure.
Patients and Outcomes
All 58 126 patients with multivessel disease (2 or more of the 3 major coronary arteries with at least 70%
stenosis) undergoing PCI between January 1, 2010, and December 31, 2012, were first identified. Patients
were then excluded if they were out-of-state residents (n = 2629), did not have a valid social security
number (n = 2255), had refractory shock (systolic blood pressure <80 mm Hg or cardiac index <2.0
L/min/m  despite pharmacologic or mechanical support [n = 282]), left main disease (n = 980), a chronic
total occlusion (n = 6433), were staged from a previous admission (n = 272), or were completely
revascularized in a subsequent admission without being noted as staged (n = 1636). Non–New York
residents were excluded because the New York vital statistics file only applies to New York residents, and
patients without social security numbers were excluded because they could not be matched to vital records
data. All remaining 41 639 patients were participants of the study. Because this was a retrospective
observational study, the University at Albany Institutional Review Board waived approval of the study, and
informed consent was not required.
Patients with PCI were defined as having CR if PCI was successfully attempted (with residual stenosis of
≤50%) in at least 1 lesion in every diseased (≥70% stenosis) major epicardial coronary vessel (proximal,
mid, and distal segments; major left anterior descending diagonals; and circumflex marginal branches)
during the index hospitalization or during a staged procedure within 60 days after discharge prior to
experiencing any myocardial infarction. Procedures were regarded as staged if they were coded as
intended to be staged in the index admission, coded as a staged procedure in the subsequent admission, and
were elective procedures.
Patients with PCI not meeting the definition of CR were regarded as patients with IR. Also, patients were
followed up through December 31, 2014, to identify all-cause mortality after having linked Percutaneous
Coronary Interventions Reporting System data with New York’s Vital Statistics data.
Statistical Analysis
Patient risk factor prevalences were compared for patients with IR and patients with CR. This was done
separately for patients with ST-elevation myocardial infarction (STEMI) and for patients without STEMI.
χ  Tests and Fisher exact tests were used to identify significant differences between patients with IR and
patients with CR for categorical variables, and the t test was used for comparing continuous variables.
Relative frequencies and unadjusted mortality rates were compared for patients who underwent CR and
patients with IR having different highest stenosis levels in IR vessels (>90% and 70%-89%), patients with
IR having different numbers of IR vessels (1 or 2 or more), and patients with IR having and not having IR
in the PLAD artery.
Cox proportional hazards models with robust sandwich covariances to account for within-hospital
clustering were used to compare mortality rates for CR patients with rates for patients whose highest IR
stenosis was in the ranges specified in previous paragraph. For these analyses and all subsequent analyses,
2 models were used to separately analyze patients with STEMI and all other patients. The binary outcome
2
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was mortality/survival. Each of the stenosis ranges was represented as a category, and the remaining
category (CR) used as the reference category. Control variables in the model included all significant risk
factors selected by cross-validation including demographics, comorbidities, left ventricular function, and
vessels diseased. The candidate patient-level predictors of mortality were all the risk factors presented in 
Table 1. A second pair of Cox models were developed to compare mortality rates for patients with IR in 1
vessel and patients with IR in 2 or more vessels with rates for patients with CR. Again, a categorical
variable was created with CR used as a reference category, and the same patient characteristics in the first
model were used as control variables. A third pair of models compared mortality for patients with CR with
the mortality for patients with IR who did and did not have IR in the PLAD vessel. All tests were 2-sided
and conducted at the .05 level of significance, and all analyses were conducted in SAS, version 9.4 (SAS
Institute).
Results
For patients with STEMI and patients without STEMI, patients with IR were older, more likely to be
black, had lower body mass indexes and ejection fractions, were more likely to have had a previous PCI
and coronary artery bypass grafting surgery, had more vessels diseased, and were more likely to have
several comorbidities (Table 1 and Table 2).
Table 3 demonstrates that among patients with STEMI undergoing PCI, 34% had an IR vessel with at least
90% stenosis, nearly one-quarter had 2 or more incompletely revascularized major epicardial vessels, and
nearly 10% had the PLAD vessel with IR. For patients with PCI without STEMI (Table 4), nearly one-
third had at least 1 IR vessel with at least 90% stenosis, one-fifth had 2 or more IR vessels, and 7% had the
PLAD vessel with IR. Also, prior to controlling for other factors related to mortality, patients with PCI
with IR with and without STEMI had higher mortality rates if they had IR in a vessel with at least 90%
stenosis (Figure, A and C), 2 or more vessels with IR (Figure, B and D), or the PLAD vessel incompletely
revascularized (eFigure in the Supplement).
As noted in Table 3, among patients with STEMI, the subgroup with IR in a vessel with at least 90%
stenosis had significantly higher 5-year risk-adjusted mortality than patients with CR (17.18% vs 8.11%;
adjusted hazard ratio [AHR], 1.49; 95% CI, 1.18-1.88), and other patients with IR also had higher
mortality than patients with CR (12.86% vs 8.11%; AHR, 1.28; 95% CI, 1.02-1.61). However, higher
mortality rates in patients with IR in a vessel with 90% or greater stenosis compared with other patients
with IR did not reach statistical significance (17.18% vs 12.86%; AHR, 1.16; 95% CI, 0.99-1.37). Among
patients without STEMI, the findings were similar (Table 4). The subgroup with IR in a vessel with at least
90% stenosis had significantly higher risk-adjusted mortality than patients with CR (17.71% vs 10.15%;
AHR, 1.36; 95% CI, 1.25-1.47), and other patients with IR also had higher mortality than patients with CR
(12.96% vs 10.15%; AHR, 1.18; 95% CI, 1.09-1.28). Patients with IR in a vessel with at least 90%
stenosis also had higher mortality than other patients with IR (17.71% vs 12.96%; AHR, 1.15; 95% CI,
1.07-1.24).
Having more vessels that were incompletely revascularized also put patients at a higher risk. Patients with
PCI with STEMI who had IR in 2 or more vessels had higher medium-term risk-adjusted mortality than
patients with CR (20.37% vs 8.08%; AHR, 1.71; 95% CI, 1.35-2.16), as did patients who had IR in a
single vessel (12.96% vs 8.08%; AHR, 1.26; 95% CI, 1.01-1.57) (Table 3). However, patients with IR in 2
or more vessels were at higher risk than other patients with IR (20.37% vs 12.96%; AHR, 1.35; 95% CI,
1.15-1.59). Among patients without STEMI, patients with IR in 2 or more vessels (20.10% vs 10.19%;
AHR, 1.42; 95% CI, 1.30-1.55) and other patients with IR (14.39% vs 10.19%; AHR, 1.22; 95% CI, 1.13-
1.31) had higher adjusted 5-year mortality than patients with CR, but patients with IR in 2 or more vessels
also had higher mortality that other patients with IR (20.10% vs 14.39%; AHR, 1.17; 95% CI, 1.09-1.59) (
Table 4).
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Table 3 and Table 4 show that patients with the PLAD vessel incompletely revascularized were also at
higher risk. Among patients with STEMI, this group had higher adjusted mortality than patients with CR
(20.09% vs 8.08%; AHR, 1.78; 95% CI, 1.33-2.37), as did other patients with IR (14.67% vs 8.08%; AHR,
1.36; 95% CI, 1.10-1.69) (Table 3). However, patients with PCI with IR in the PLAD vessel had higher
mortality than other IR patients (20.09% vs 14.67%; AHR, 1.31; 95% CI, 1.04-1.64). Similar findings
occurred among patients without STEMI (Table 4). Patients with IR in the PLAD vessel had higher
adjusted mortality than patients with CR (20.78% vs 10.19%; AHR, 1.40; 95% CI, 1.25-1.57), as did other
IR patients (15.62% vs 10.19%; AHR, 1.26; 95% CI, 1.17-1.35), but patients with PCI with IR in the
PLAD vessel had higher mortality than other patients with IR (20.78% vs 15.62%; AHR, 1.11; 95% CI,
1.01-1.23).
Discussion
Numerous earlier observational studies have demonstrated that patients with multivessel disease
undergoing PCI with IR have higher mortality rates than their counterparts who undergo CR. However, we
are not aware of any studies that have investigated whether patients undergoing PCI with IR are at
differential risk of mortality based on the specific vessels that are incompletely revascularized, the stenosis
in those vessels, or the number of vessels that are incompletely revascularized. The purpose of this study
was to investigate the association of those factors with medium-term mortality outcomes (median follow-
up, 3.4 years).
We found that patients with PCI who had at least 1 vessel with 90% stenosis that was not revascularized,
as well as other patients with IR, were at higher risk of mortality than patients with CR, but the group with
IR in a vessel with at least 90% stenosis was also at higher risk than other patients with IR. This was not
significant among patients with STEMI and significant among patients without STEMI. Surprisingly, 34%
of patients with STEMI (n = 1874) and 32% of patients without STEMI (n = 10 205) underwent PCI with
at least 1 vessel with 90% stenosis not revascularized.
Also, although patients with 1 vessel incompletely revascularized had higher risk-adjusted mortality than
patients with CR, patients with IR in 2 or more vessels had higher mortality than patients with CR and
higher mortality than other patients with IR. We found this to be true both among patients with STEMI and
among patients without STEMI. Furthermore, more than 20% of both patients with STEMI and patients
without STEMI had IR in 2 or more vessels.
In addition, patients with IR in the PLAD vessel, regardless of whether they had STEMI, had higher
adjusted mortality rates than other patients with IR as well as patients with CR. Eight percent of patients
with STEMI had IR in the PLAD vessel compared with 7% of patients without STEMI.
Earlier findings from the same database demonstrate that a very high percentage of PCI with IR (96%)
occur because of unattempted CR, not because of unsuccessful attempts at CR. This is pertinent because it
indicates that IRs among patients with high-risk characteristics, such as multivessel IR and IR in vessel
with high stenosis levels, are planned in advance when other options could be considered.
Limitations
As with all observational studies, a caveat of this study is selection bias. Patients with IR in general and
patients with IR with higher stenosis and more vessels incompletely revascularized may have worse
outcomes because they are sicker and have more comorbidities than patients with CR. There are factors
related to mortality and/or choice of CR vs IR that we did not have access to such as adequate functional
revascularization, lesion complexity, frailty, malignancies, bleeding risks, contrast volume, and radiation
dose. Also, we had no information related to patient preferences.
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We tried to minimize selection bias by using Cox proportional hazards models to control for differences in
the prevalence of numerous factors related to mortality and choice of CR including ventricular function,
extent of coronary artery disease, and comorbidities. Also, staged procedures resulting in CR within 60
days were counted as CR so that the prevalence of CR would not be erroneously underestimated for high-
risk patients. Nevertheless, an observational study cannot fully address causality, and the outcome
differences identified in our study may still be related to differences in patients’ severity of illness.
Another limitation of the study is that we did not have access to cause of death, so we were unable to
capture cardiac deaths. It is possible that our conclusions may have been different if the study had been
limited to cardiac deaths, although cause of death is frequently difficult to confirm.
Conclusions
Patients undergoing IR in vessels with very high stenosis levels (≥90%), multivessel IR, or IR in the
PLAD are at even higher risk of mortality. A relatively high percentage of patients with PCI undergo IR
with these higher-risk conditions.
Notes
Supplement.
eFigure. Four-Year Survival Curves for Complete Revascularization and for Incomplete
Revascularization by Proximal Left Anterior Descending Artery Disease
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Table 1.
Patient Risk Factors for Patients With ST-Elevation Myocardial Infarction Undergoing PCI
With Complete and Incomplete Revascularization
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Open in a separate window
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared);
CABG, coronary artery bypass grafting; CR, complete revascularization; IR, incomplete revascularization; MI,
myocardial infarction; NA, not applicable; PCI, percutaneous coronary interventions.
SI conversion factor: To convert creatinine to micromoles per liter, multiply by 88.4.
Two-sample t test.
Fisher exact test.
Risk Factor No. (%) P Value
Total CR IR
Patients 5646 1226 4420 NA
Age, mean (SD), y 62.8 (12.7) 60.6 (11.8) 63.4 (12.9) <.001
Female 1481 (26.2) 301 (24.6) 1180 (26.7) .13
Hispanic ethnicity 669 (11.8) 130 (10.6) 539 (12.2) .13
Race/ethnicity
White 4602 (81.5) 1019 (83.1) 3583 (81.1)
.007
Black 520 (9.2) 99 (8.1) 421 (9.5)
Asian 296 (5.2) 75 (6.1) 221 (5.0)
Other 228 (4.0) 33 (2.7) 195 (4.4)
BMI
<18.5 61 (1.1) 5 (0.4) 56 (1.3)
.003
18.5-24.9 1349 (23.9) 254 (20.7) 1095 (24.8)
25.0-30.0 2282 (40.4) 512 (41.8) 1770 (40.0)
30.1-34.9 1275 (22.6) 289 (23.6) 986 (22.3)
35.0-40.0 470 (8.3) 113 (9.2) 357 (8.1)
>40.0 209 (3.7) 53 (4.3) 156 (3.5)
Ejection fraction, %
<20 96 (1.7) 10 (0.8) 84 (1.9)
<.001
20-29 408 (7.2) 59 (4.8) 349 (7.9)
30-39 839 (14.9) 139 (11.3) 700 (15.8)
40-49 1672 (29.6) 389 (31.7) 1283 (29.0)
≥50 2633 (46.6) 629 (51.3) 2004 (45.3)
Previous PCIs 896 (15.9) 150 (12.2) 746 (16.7) <.001
Carotid/cerebrovascular disease 312 (5.5) 53 (4.3) 259 (5.9) .04
Peripheral vascular disease 261 (4.6) 38 (3.1) 223 (5.0) .004
Hemodynamic instability 208 (3.7) 27 (2.2) 181 (4.1) .002
Congestive heart failure
None 5351 (94.8) 1195 (97.5) 4156 (94.0)
a
a
b
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Table 2.
Patient Risk Factors for Patients Without ST-Elevation Myocardial Infarction Undergoing
PCI With Complete and Incomplete Revascularization
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Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared);
CABG, coronary artery bypass grafting; CR, complete revascularization; IR, incomplete revascularization; MI,
myocardial infarction; NA, not applicable; PCI, percutaneous coronary interventions.
SI conversion factor: To convert creatinine to micromoles per liter, multiply by 88.4.
Two-sample t test.
Fisher exact test.
Risk Factor No. (%) P Value
Total CR IR
Patients 35 993 10 261 25 732 NA
Age, mean (SD), y 66.6 (11.5) 65.0 (11.5) 67.2 (11.5) <.001
Female 10458 (29.1) 3115 (30.4) 7343 (28.5) .001
Hispanic ethnicity 4062 (11.3) 982 (9.6) 3080 (12.0) <.001
Race/ethnicity
White 28476 (79.1) 8249 (80.4) 20227 (78.6)
<.001
Black 3803 (10.6) 981 (9.6) 2822 (11.0)
Asian 3033 (8.4) 882 (8.6) 2151 (8.4)
Other 681 (1.9) 149 (1.5) 532 (2.1)
BMI
<18.5 292 (0.8) 82 (0.8) 210 (0.8)
.001
18.5-24.9 7308 (20.3) 1934 (18.8) 5374 (20.9)
25.0-30.0 13742 (38.2) 3955 (38.5) 9787 (38.0)
30.1-34.9 8888 (24.7) 2629 (25.6) 6259 (24.3)
35.0-40.0 3712 (10.3) 1060 (10.3) 2652 (10.3)
>40.0 2051 (5.7) 601 (5.9) 1450 (5.6)
Ejection fraction, %
<20 270 (0.8) 47 (0.5) 223 (0.9)
<.001
20-29 1409 (3.9) 295 (2.9) 1114 (4.3)
30-39 2382 (6.6) 470 (4.6) 1912 (7.4)
40-49 5288 (14.7) 1318 (12.8) 3970 (15.4)
≥50 26644 (74.0) 8131 (79.2) 18513 (71.9)
Previous PCIs 12631 (35.1) 2867 (27.9) 9764 (37.9) <.001
Previous MI 15783 (43.9) 4010 (39.1) 11773 (45.8) <.001
Carotid/cerebrovascular disease 3846 (10.7) 848 (8.3) 2998 (11.7) <.001
Peripheral vascular disease 3614 (10.0) 721 (7.0) 2893 (11.2) <.001
Hemodynamic instability 83 (0.2) 14 (0.1) 69 (0.3) .02
Congestive heart failure
a
a
b
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Table 3.
Frequencies, Unadjusted All-Cause Mortality Rates,  and Adjusted HRs for 5646 Patients
With STEMI  Undergoing PCIs With Incomplete Revascularization: New York, 2010-2012
Type of Revascularization No. (%) Observed Mortality Rate,
%
Adjusted HR  (95%
CI)
P
Value
Complete revascularization 1220
(22.29)
8.11 1 [Reference] NA
Highest stenosis in incomplete lesion,
%
70-89 2380
(43.48)
12.86 1.28 (1.02-1.61) .03
>90 1874
(34.23)
17.18 1.49 (1.18-1.88) .001
(>90 vs 70-89) NA NA 1.16 (0.99-1.37) .08
Vessels incomplete, No.
None 1226
(21.71)
8.08 1 [Reference] NA
1 3065
(54.29)
12.95 1.26 (1.01-1.57) .04
2 or more 1355
(24.00)
20.37 1.71 (1.35-2.16) <.001
2 or more vs 1 NA NA 1.35 (1.15-1.59) <.001
Location of incomplete vessel
Complete revascularization 1226
(21.71)
8.08 1 [Reference] NA
Not PLAD 3967
(70.26)
14.67 1.36 (1.10-1.69) .005
PLAD 453 (8.02) 20.09 1.78 (1.33-2.37) <.001
PLAD vs not PLAD NA NA 1.31 (1.04-1.64) .02
Abbreviations: HR, hazard ratio; NA, not applicable; PCI, percutaneous coronary interventions; PLAD, proximal left
anterior descending; STEMI, ST-elevation myocardial infarction.
Median follow-up, 3.4 years.
Within 24 hours before PCI.
Adjusted for significant risk factors selected by cross-validation including age, body mass index, ejection fraction,
hemodynamic instability, congestive heart failure, malignant ventricular arrhythmia, chronic obstructive pulmonary
disease, diabetes, and renal failure.
Excluded 4440 patients with PCI in bypassed vessel because there was no information about percentage of stenosis
for those patients.
a
b
c
d
a
b
c
d
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Table 4.
Frequencies, Unadjusted All-Cause Mortality Rates,  and Adjusted HRs for Patients Without
STEMI  Undergoing PCI With Incomplete Revascularization: New York, 2010-2012 (N = 35 
993)
Type of Revascularization No. (%) Observed Mortality
Rate, %
Adjusted HR  (95%
CI)
P
Value
Complete revascularization 10 059
(31.71)
10.15 1 [Reference] NA
Highest stenosis in incomplete
lession, %
70-89 11 461
(36.13)
12.96 1.18 (1.09-1.28) <.001
>90 10 205
(32.17)
17.71 1.36 (1.25-1.47) <.001
>90 vs 70-89 NA NA 1.15 (1.07-1.24) <.001
Vessels incomplete, No.
None 10 261
(28.51)
10.19 1 [Reference] NA
1 17 925
(49.50)
14.39 1.22 (1.13-1.31) <.001
2 or more 7807 (21.69) 20.10 1.42 (1.30-1.55) <.001
2 or more vs 1 NA NA 1.17 (1.09-1.59) <.001
Location of incomplete vessel
Complete Revascularization 10 261
(28.51)
10.19 1 [Reference] NA
Not PLAD 23 230
(64.54)
15.62 1.26 (1.17-1.35) <.001
PLAD 2502 (6.95) 20.78 1.40 (1.25-1.57) <.001
PLAD vs not PLAD NA NA 1.11 (1.01-1.23) .03
Abbreviations: HR, hazard ratio; NA, not applicable; PCI, percutaneous coronary interventions; PLAD, proximal left
anterior descending; STEMI, ST-elevation myocardial infarction.
Median follow-up, 3.4 years.
Within 24 hours before PCI.
Adjusted for significant risk factors selected by cross-validation including age, race/ethnicity, body mass index,
ejection fraction, time of previous MI, cerebrovascular disease, peripheral vascular disease, hemodynamic instability,
congestive heart failure, malignant ventricular arrhythmia, chronic obstructive pulmonary disease, diabetes, renal
failure, previous coronary artery bypass grafting surgery, emergency PCI owing to diagnostic catheterization
complication, and previous organ transplant.
Excluded 4440 patients with PCI in bypassed vessel because there was no information about percentage of stenosis
for those patients.
a
b
c
d
a
b
c
d
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Figure.
Four-Year Survival for Patients With Complete Revascularization (CR) and Incomplete Revascularization (IR)
A, Patients with ST-elevation myocardial infarction (STEMI) with subgroups of patients with IR based on severity of
nonrevascularized stenoses. B, Patients with STEMI with subgroups of patients with IR based on number of
nonrevascularized vessels. C, Patients without STEMI with subgroups of patients with IR based on severity of
nonrevascularized stenosis. D, Patients with STEMI with subgroups of patients with IR based on number of
nonrevascularized vessels.
Excluded 4440 patients with percutaneous coronary interventions (PCIs) in bypass grafts because there was no
information about percentage of stenosis for those patients.
a
